Related Experiment Videos

Insulin resistance and lipodystrophy in mice lacking ribosomal S6 kinase 2

Karim El-Haschimi1, Scott D Dufresne, Michael F Hirshman

  • 1Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA.

Diabetes
|May 27, 2003
PubMed

Insights

p90 ribosomal S6 kinase 2 (RSK2) deficiency in mice reduces adipose tissue mass and impairs glucose tolerance. This suggests RSK2 is crucial for regulating body fat and metabolic health.

Area of Science:

  • Biochemistry
  • Physiology
  • Metabolic Research

Background:

  • p90 ribosomal S6 kinase 2 (RSK2) is a serine/threonine kinase highly expressed in adipose tissue.
  • In vitro studies suggest RSK2 regulates various cellular processes, but its in vivo physiological role is unclear.

Purpose of the Study:

  • To investigate the in vivo function of RSK2 using knockout (KO) mice.
  • To elucidate the role of RSK2 in regulating adipose tissue mass and metabolic homeostasis.

Main Methods:

  • Generation and analysis of rsk2 knockout (KO) mice.
  • Assessment of body weight, adipose tissue mass, serum leptin levels, glucose tolerance, and insulin levels.
  • Evaluation of leptin administration effects on KO mice.

Main Results:

  • RSK2 KO mice exhibit reduced body weight with age, primarily due to loss of white adipose tissue.
  • KO mice show decreased serum leptin levels, impaired glucose tolerance, and elevated fasting insulin and glucose.
  • Leptin administration partially restored glucose homeostasis in KO mice without affecting food intake.

Conclusions:

  • RSK2 plays a significant role in regulating adipose mass in mice.
  • Reduced adipose tissue in RSK2 KO mice may lead to insulin sensitivity issues, similar to human lipodystrophy, via decreased adipocyte-derived factors like leptin.

Related Concept Videos